Adding aromatherapy to recovery protocol may decrease postoperative anxiety and pain

News
Article

Following oculoplastic surgery, patients who underwent aromatherapy had shorter stays in the post-anesthesia care unit

Bottles of essential oils are placed next to an essential oil aromatherapy diffuser in a calm, warm, spa-like environment. Image credit: ©Botamochy – stock.adobe.com

The study findings support using aromatherapy as an adjuvant analgesic/anxiolytic. Image credit: ©Botamochy – stock.adobe.com

Aromatherapy may be a useful addition to help patients who are undergoing oculoplastic procedures under monitored anesthetic sedation. In this study, the use of aromatherapy resulted in lower postoperative anxiety and pain scores,1 according to patient reporting.

First author Michael Chang, MD, from Department of Ophthalmology and Visual Sciences, West Virginia University School of Medicine, Morgantown, WV, and colleagues reported their results in Ophthalmic Plastic and Reconstructive Surgery.

The investigators conducted a randomised controlled trial that included 60 patients who underwent monitored anaesthesia care sedation for oculoplastic procedures from August 2018 to November 2020.

A total of 32 patients were randomised to an aromatherapy and 28 to placebo. Anxiety was measured using the State-Trait Anxiety Inventory and visual analogue scale for anxiety, and pain was measured with a visual analogue scale for pain, the authors recounted.

They reported that the patients randomised to aromatherapy had significantly lower scores for both parameters measured postoperatively. The patient and control scores on the State-Trait Anxiety Inventory state anxiety scale were, respectively, 24.1 and 29.1, and the respective visual analogue scale pain scores were 1.9 and 3.2 (P = 0.05 for both comparisons).

In addition, the patients randomised to aromatherapy also had shorter stays in the post-anaesthesia care unit compared with the control patients, ie, 57.7 and 79.4 minutes, respectively (P = 0.03).

Dr Chang and colleagues concluded, “The patients who received aromatherapy reported lower postoperative anxiety and pain. Aromatherapy may be a useful adjuvant analgesic and/or anxiolytic for patients undergoing oculoplastic procedures with monitored anesthesia care sedation.”

Reference

1. Chang M, Schaefer J, Leonard A, et al. The effect of aromatherapy on anxiety and pain in patients undergoing oculoplastic surgery. Ophthalmic Plast Reconstr Surg. 2024;40:677-680; DOI: 10.1097/IOP.0000000000002692

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.